Home・Elenco Azioni・Medpace Holdings Inc

Medpace Holdings Inc

Chiusa

SettoreSettore sanitario

572.76 -2.35

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

586.08

Massimo

602.83

Metriche Chiave
By Trading Economics
Entrata	-11M 124M
Vendite	-1.8M 707M
P/E Media del settore	33.224 62.58
EPS	4.28
Margine di Profitto	17.53
Dipendenti	6,300
EBITDA	-9.5M 154M

Raccomandazioni
By TipRanks
Raccomandazioni	Neutrale
Previsioni per 12 mesi	-3.52% downside

Dividendi
By Acuity
Utili prossimi	21 ott 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-14M 15B
Apertura precedente	575.11
Chiusura precedente	572.76

Notizie sul Sentiment di mercato

By Acuity

50%

155 / 340 Classifica in Healthcare

Medpace Holdings Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

27 lug 2026, 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24 lug 2026, 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22 lug 2026, 23:22 UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 lug 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Confronto tra pari

Modifica del prezzo

Medpace Holdings Inc Previsione

Obiettivo di Prezzo

By TipRanks

-3.52% in calo

Previsioni per 12 mesi

Media 580.2 USD -3.52%

Alto 692 USD

Basso 450 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Medpace Holdings Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

11 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 11 che hanno fornito valutazioni azionarie a Medpace Holdings Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

155 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.